310 related articles for article (PubMed ID: 8915781)
41. Effect of Crohn's disease on bone metabolism in vitro: a role for interleukin-6.
Sylvester FA; Wyzga N; Hyams JS; Gronowicz GA
J Bone Miner Res; 2002 Apr; 17(4):695-702. PubMed ID: 11918227
[TBL] [Abstract][Full Text] [Related]
42. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures.
Romas E; Udagawa N; Zhou H; Tamura T; Saito M; Taga T; Hilton DJ; Suda T; Ng KW; Martin TJ
J Exp Med; 1996 Jun; 183(6):2581-91. PubMed ID: 8676079
[TBL] [Abstract][Full Text] [Related]
43. Interleukin-6 messenger RNA expression and interleukin-6 protein secretion in cells isolated from normal human bone: regulation by interleukin-1.
Linkhart TA; Linkhart SG; MacCharles DC; Long DL; Strong DD
J Bone Miner Res; 1991 Dec; 6(12):1285-94. PubMed ID: 1792940
[TBL] [Abstract][Full Text] [Related]
44. Endogenous production of tumor necrosis factor by primary cultures of murine calvarial cells: influence on IL-6 production and osteoclast development.
Passeri G; Girasole G; Manolagas SC; Jilka RL
Bone Miner; 1994 Feb; 24(2):109-26. PubMed ID: 8199531
[TBL] [Abstract][Full Text] [Related]
45. Natural killer (NK) cell generation in bone marrow cultures: role of IL-1 alpha.
Ayroldi E; Cannarile L; Riccardi C
Immunopharmacol Immunotoxicol; 1991; 13(4):589-606. PubMed ID: 1774437
[TBL] [Abstract][Full Text] [Related]
46. 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.
Girasole G; Jilka RL; Passeri G; Boswell S; Boder G; Williams DC; Manolagas SC
J Clin Invest; 1992 Mar; 89(3):883-91. PubMed ID: 1541679
[TBL] [Abstract][Full Text] [Related]
47. The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice.
Probert L; Plows D; Kontogeorgos G; Kollias G
Eur J Immunol; 1995 Jun; 25(6):1794-7. PubMed ID: 7615010
[TBL] [Abstract][Full Text] [Related]
48. Characterization and hormonal modulation of IL-1 binding in neonatal mouse osteoblastlike cells.
Shen V; Cheng SL; Kohler NG; Peck WA
J Bone Miner Res; 1990 May; 5(5):507-15. PubMed ID: 2142376
[TBL] [Abstract][Full Text] [Related]
49. The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro.
Littlewood AJ; Russell J; Harvey GR; Hughes DE; Russell RG; Gowen M
Endocrinology; 1991 Sep; 129(3):1513-20. PubMed ID: 1714833
[TBL] [Abstract][Full Text] [Related]
50. Retarded liver growth in interleukin-6-deficient and tumor necrosis factor receptor-1-deficient mice.
Wallenius V; Wallenius K; Hisaoka M; Sandstedt J; Ohlsson C; Kopf M; Jansson JO
Endocrinology; 2001 Jul; 142(7):2953-60. PubMed ID: 11416016
[TBL] [Abstract][Full Text] [Related]
51. Interleukin-6 is produced by bone and modulated by parathyroid hormone.
Feyen JH; Elford P; Di Padova FE; Trechsel U
J Bone Miner Res; 1989 Aug; 4(4):633-8. PubMed ID: 2816508
[TBL] [Abstract][Full Text] [Related]
52. Deletion of membrane-bound steel factor results in osteopenia in mice.
Lotinun S; Evans GL; Turner RT; Oursler MJ
J Bone Miner Res; 2005 Apr; 20(4):644-52. PubMed ID: 15765184
[TBL] [Abstract][Full Text] [Related]
53. Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors.
Kassem M; Harris SA; Spelsberg TC; Riggs BL
J Bone Miner Res; 1996 Feb; 11(2):193-9. PubMed ID: 8822343
[TBL] [Abstract][Full Text] [Related]
54. In vivo demonstration that parathyroid hormone and parathyroid hormone-related protein stimulate expression by osteoblasts of interleukin-6 and leukemia inhibitory factor.
Pollock JH; Blaha MJ; Lavish SA; Stevenson S; Greenfield EM
J Bone Miner Res; 1996 Jun; 11(6):754-9. PubMed ID: 8725172
[TBL] [Abstract][Full Text] [Related]
55. Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariae.
al-Humidan A; Ralston SH; Hughes DE; Chapman K; Aarden L; Russell RG; Gowen M
J Bone Miner Res; 1991 Jan; 6(1):3-8. PubMed ID: 2048428
[TBL] [Abstract][Full Text] [Related]
56. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation.
Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D
J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486
[TBL] [Abstract][Full Text] [Related]
57. Tumor necrosis factor receptor 1 signaling resistance in the female myocardium during ischemia.
Wang M; Tsai BM; Crisostomo PR; Meldrum DR
Circulation; 2006 Jul; 114(1 Suppl):I282-9. PubMed ID: 16820587
[TBL] [Abstract][Full Text] [Related]
58. The bone marrow microenvironment contributes to type I diabetes induced osteoblast death.
Coe LM; Irwin R; Lippner D; McCabe LR
J Cell Physiol; 2011 Feb; 226(2):477-83. PubMed ID: 20677222
[TBL] [Abstract][Full Text] [Related]
59. Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6.
Miyaura C; Kusano K; Masuzawa T; Chaki O; Onoe Y; Aoyagi M; Sasaki T; Tamura T; Koishihara Y; Ohsugi Y
J Bone Miner Res; 1995 Sep; 10(9):1365-73. PubMed ID: 7502709
[TBL] [Abstract][Full Text] [Related]
60. Induction of early growth response-1 gene by interleukin-1 beta and tumor necrosis factor-alpha in normal human bone marrow stromal an osteoblastic cells: regulation by a protein kinase C inhibitor.
Chaudhary LR; Cheng SL; Avioli LV
Mol Cell Biochem; 1996 Mar; 156(1):69-77. PubMed ID: 8709978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
